J. Anderson

发表

Alzheimer's disease-associated reduction of polysomal mRNA translation.

B. Winblad, N. Langstrom, J. Anderson, 1989, Brain research. Molecular brain research.

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.

I. Kola, R. Motter, K. Johnson-wood, 2001, Human molecular genetics.

The genesis of the senile plaque. Further evidence in support of its neuronal origin.

N. Robakis, J. Anderson, M. Pappolla, 1992, The American journal of pathology.

Chondroitin sulfate proteoglycan form of the Alzheimer's beta-amyloid precursor.

J. Shioi, N. Robakis, J. Anderson, 1992, The Journal of biological chemistry.

Differential brain expression of the Alzheimer's amyloid precursor protein.

V. Haroutunian, N. Robakis, L. Bierer, 1989, The EMBO journal.

Recent Advances in the Understanding of the Processing of APP to Beta Amyloid Peptide

L. McConlogue, D. Schenk, E. Thorsett, 2000, Annals of the New York Academy of Sciences.

Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells

J. Shioi, N. Robakis, J. Anderson, 1992, Journal of neuroscience research.

The interaction of calmodulin with human erythrocyte spectrin. Inhibition of protein 4.1-stimulated actin binding.

J. Anderson, J. Morrow, 1987, The Journal of biological chemistry.

Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain

F. D. Miller, R. Motter, D. Kholodenko, 2000, Journal of neurochemistry.

In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain

R. Motter, M. Bergeron, D. Fauss, 2014, Neuroscience.

Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures.

N. Robakis, L. Refolo, J. Anderson, 1989, Biochemical and biophysical research communications.